Geschlechtsspezifische Unterschiede in uro-onkologischen Studien

Translated title of the contribution: Gender-/Sex-Specific Differences in Clinical Trials in Uro-Oncology

Abstract

Subgroup analyses in clinical trials sometimes reveal gender-/sex-dependent differences in cancer outcomes. However, drug approvals are rarely restricted to a specific sex or gender, and recommendations regarding dosage are rarely tailored accordingly. Furthermore, discrepancies exist between the gender-/sex-dependent enrollment rates in clinical trials and real-world incidence or mortality rates. This article highlights gender-/sex differences in clinical trials in uro-oncology.

Translated title of the contributionGender-/Sex-Specific Differences in Clinical Trials in Uro-Oncology
Original languageGerman
JournalAktuelle Urologie
Volume56
Issue number2
Pages (from-to)131-134
Number of pages4
ISSN0001-7868
DOIs
Publication statusPublished - 28.01.2025

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)

DFG Research Classification Scheme

  • 2.22-23 Reproductive Medicine, Urology
  • 2.22-14 Hematology, Oncology

Fingerprint

Dive into the research topics of 'Gender-/Sex-Specific Differences in Clinical Trials in Uro-Oncology'. Together they form a unique fingerprint.

Cite this